Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab in Locally Advanced Sinonasal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
- Status
- RECRUITING
- Phase
- PHASE2
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
- Status
- RECRUITING
- Phase
- PHASE2
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
- Status
- RECRUITING
- Phase
- NA
Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC
- Status
- RECRUITING
- Phase
- PHASE3
Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
- Status
- RECRUITING
- Phase
- PHASE3
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
- Status
- UNKNOWN
- Phase
- NA
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE1